InvestorsHub Logo
Followers 52
Posts 2230
Boards Moderated 0
Alias Born 07/06/2011

Re: loanranger post# 146180

Friday, 02/23/2024 12:27:55 PM

Friday, February 23, 2024 12:27:55 PM

Post# of 146201
Yes, a US trial with big pharma sponsor, FDA IND, listing on Clinicaltrials.gov, and all the rest would give legitimacy to NNVC as an actual drug development company.

I did appreciate you noticing the "love letter," and have to admit it is/was suspicious how it took them so long to actually try to put their drugs into people, not to mention all the eggregious conflicts of interest. It has been clear that Diwan's rules of business are #1: Diwan comes first.

Perhaps he finally has siphoned off enough dough and is old enough that he finally will see what he has come up with? The NNVC BOD apparently asked him to withhold the development milestone payments until there is actual revenue. I suppose it was good of Diwan to put up $2M line of credit from himself to his company (in order to satisfy the going concerns / 12 mo of funds?) It was good to see that NNVC deal with Indian company gives 70% of sales to NNVC. I guess that means 30% to Diwan-India, 30% to Diwan-Theracour, and 40% for NNVC investors (of which Diwan is what, 10%?) So Diwan proves his business acumen once again in that any Indian sales of his drug goes ~50 cents on the dollar into his pocket, or something like that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News